BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34568038)

  • 1. Development and Validation of a
    Ouyang ML; Wang YR; Deng QS; Zhu YF; Zhao ZH; Wang L; Wang LX; Tang K
    Front Oncol; 2021; 11():710909. PubMed ID: 34568038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[
    Xu L; Huang G; Wang Y; Huang G; Liu J; Chen R
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1729-1740. PubMed ID: 38150017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
    Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
    Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xue XQ; Yu WJ; Shi X; Shao XL; Wang YT
    Front Oncol; 2022; 12():911168. PubMed ID: 36003788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer.
    Ren C; Zhang F; Zhang J; Song S; Sun Y; Cheng J
    Eur J Med Res; 2023 Dec; 28(1):554. PubMed ID: 38042812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Nomogram Combining CT Imaging with Clinical Features for Prediction of Lymph Node Metastasis in Stage I-IIIB Non-small Cell Lung Cancer.
    Zheng X; Shao J; Zhou L; Wang L; Ge Y; Wang G; Feng F
    Ther Innov Regul Sci; 2022 Jan; 56(1):155-167. PubMed ID: 34699046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
    Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
    Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PET/CT nomogram incorporating SUVmax and CT radiomics for preoperative nodal staging in non-small cell lung cancer.
    Xie Y; Zhao H; Guo Y; Meng F; Liu X; Zhang Y; Huai X; Wong Q; Fu Y; Zhang H
    Eur Radiol; 2021 Aug; 31(8):6030-6038. PubMed ID: 33560457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of a CT-based lymph node radiomics nomogram in detecting lymph node metastasis in PDAC patients.
    Li Q; Song Z; Zhang D; Li X; Liu Q; Yu J; Li Z; Zhang J; Ren X; Wen Y; Tang Z
    Front Oncol; 2022; 12():992906. PubMed ID: 36276058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An [
    Meng N; Feng P; Yu X; Wu Y; Fu F; Li Z; Luo Y; Tan H; Yuan J; Yang Y; Wang Z; Wang M
    Eur Radiol; 2024 Jan; 34(1):318-329. PubMed ID: 37530809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
    Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
    PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.
    Sha X; Gong G; Qiu Q; Duan J; Li D; Yin Y
    BMC Med Imaging; 2020 Feb; 20(1):12. PubMed ID: 32024469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Radiomics Nomogram Based on
    Yang B; Zhong J; Zhong J; Ma L; Li A; Ji H; Zhou C; Duan S; Wang Q; Zhu C; Tian J; Zhang L; Wang F; Zhu H; Lu G
    Front Oncol; 2020; 10():1042. PubMed ID: 32766134
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
    Wang M; Liu L; Dai Q; Jin M; Huang G
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative prediction of lymph node metastasis in colorectal cancer using
    Wang Y; Zhao H; Fu P; Tian L; Su Y; Lyu Z; Gu W; Wang Y; Liu S; Wang X; Zheng H; Du J; Zhang R
    Med Phys; 2024 May; ():. PubMed ID: 38801340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
    Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
    Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer.
    Wumener X; Zhang Y; Wang Z; Zhang M; Zang Z; Huang B; Liu M; Huang S; Huang Y; Wang P; Liang Y; Sun T
    Front Oncol; 2022; 12():1005924. PubMed ID: 36439506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.